Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
UNIVERSITE DE STRASBOURG has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution suggests that the university's research covers diverse biological or pharmaceutical applications that require review by different specialized groups within the patent office, each with its own set of examination guidelines.
FERNANDEZ, SUSAN EMILY is the busiest examiner for this portfolio, currently handling 1 pending office action. With 2 distinct examiners each managing one of the 2 pending actions, the university must coordinate 2 separate prosecution tracks. The involvement of 2 distinct art units further indicates that the technical challenges for each application may vary based on the specific sub-field of biotechnology. To successfully navigate this portfolio, the applicant must address the unique concerns of each examiner while managing the complexities inherent in having 2 pending office actions across different specialized units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERNANDEZ, SUSAN EMILY | 1 | 52.5% | +60.8% |
| HYUN, PAUL SANG HWA | 1 | 69.8% | +36.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18834670 | METHOD FOR MICROFLUIDIC QUANTIFICATION, GROWTH MONITORING AND SEPARATION OF MICROORGANISMS IN DROPLETS | FERNANDEZ, SUSAN EMILY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17764686 | PLATELET RELEASE SYSTEM AND PLATELET RELEASE METHOD | HYUN, PAUL SANG HWA | 17d overdue |
| 18834670 | METHOD FOR MICROFLUIDIC QUANTIFICATION, GROWTH MONITORING AND SEPARATION OF MICROORGANISMS IN DROPLETS | FERNANDEZ, SUSAN EMILY | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18834670 | METHOD FOR MICROFLUIDIC QUANTIFICATION, GROWTH MONITORING AND SEPARATION OF MICROORGANISMS IN DROPLETS | FERNANDEZ, SUSAN EMILY | 1651 | §103§112 | Non-Final OA | — | Pending | Jul 31, 2024 |
| 17764686 | PLATELET RELEASE SYSTEM AND PLATELET RELEASE METHOD | HYUN, PAUL SANG HWA | 1796 | §103 | Final Rejection | 17d overdue | Pending | Mar 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial